The synergistic relationship between Alzheimer's disease and sleep disorders: An update

Journal of Alzheimer's Disease

Volumn 46, Issue 3, 2015, Pages 571-580

  Villa, Chiara ^a   Ferini Strambi, Luigi ^b   Combi, Romina ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Alzheimer's disease; amyloid ; mild cognitive impairment; sleep disorders

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMYLOID BETA PROTEIN; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; OREXIN;

ALZHEIMER DISEASE; CIRCADIAN RHYTHM SLEEP DISORDER; COMORBIDITY; DAYTIME SOMNOLENCE; EXCESSIVE DAYTIME SLEEPINESS; GENETIC SUSCEPTIBILITY; HUMAN; INSOMNIA; MILD COGNITIVE IMPAIRMENT; NONHUMAN; NONREM SLEEP; PERIODIC LIMB MOVEMENT DISORDER; PRIORITY JOURNAL; REM SLEEP; RESTLESS LEGS SYNDROME; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP WAKING CYCLE; SLOW WAVE SLEEP; COMPLICATION; SLEEP WAKE DISORDERS;

ALZHEIMER DISEASE; HUMANS; SLEEP WAKE DISORDERS;

EID: 84929355062     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150138     Document Type: Review

References (82)

1. Walker MP (2009) The role ofsleepin cognition and emotion. Ann N Y Acad Sci 1156, 168-197.
2. Moran M, Lynch CA, Walsh C, Coen R, Coakley D, Lawlor BA (2005) Sleep disturbance inmild tomoderate Alzheimer's disease. Sleep Med 6, 347-352.
3. McCurry SM, Reynolds CF, Ancoli-Israel S, Teri L, Vitiello MV (2004) Treatment of sleep disturbance in Alzheimer's disease. Sleep Med Rev 4, 603-628.
4. Bliwise DL (2004) Sleep disordersinAlzheimer's disease and other dementias. Clin Cornerstone 6(Suppl 1A), S16-S28.
5. Mulin E, Zeitzer JM, Friedman L, Le Duff F, Yesavage J, Robert PH, David R (2011) Relationship between apathy and sleep disturbance in mild and moderate Alzheimer's disease: an actigraphic study. J Alzheimers Dis 25, 85-91.
6. Shin HY, Han HJ, Shin DJ, Park HM, Lee YB, Park KH (2014) Sleep problems associated with behavioral and psychological symptoms as well as cognitive functions in Alzheimer's disease. J Clin Neurol 10, 203-209.
7. Pat-Horenczyk R, Klauber MR, Shochat T, Ancoli-Israel S (1998) Hourly profiles of sleep and wakefulness in severely versus mild-moderately demented nursing home patients. Aging (Milano) 10, 308-315.
8. Ju YE, Lucey BP, Holtzman DM (2014) Sleep and Alzheimer diseasepathology-a bidirectionalrelationship.Nat Rev Neurol 10, 115-119.
9. Beaulieu-Bonneau S, Hudon C (2009) Sleep disturbances in older adults with mild cognitive impairment. Int Psychogeri-atr 21, 654-666.
10. Neikrug AB, Ancoli-Israel S (2010) Sleep disorders in the older adult-a mini-review. Gerontology 56, 181-189.
11. Espiritu JR (2008) Aging-related sleep changes. Clin Geriatr Med 24, 1-14.
12. Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV (2004) Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 27, 1255-1273.
13. Bliwise DL (1993) Sleep in normal aging and dementia. Sleep 16, 40-81.
14. Reynolds CF 3rd, Monk TH, Hoch CC, Jennings JR, Buysse DJ, Houck PR, Jarrett DB, Kupfer DJ (1991) Electroen-cephalographic sleep in the healthy "Old Old"; a comparison with the "Young Old" in visually scored and automated measures. J Gerontol 46, M39-M46.
15. Carrier J, Monk TH, Buysse DJ, Kupfer DJ (1997) Sleep and morningness-eveningness in the 'middle' years of life (20-59 y). J Sleep Res 6, 230-237.
16. Lombardo P, Formicola G, Gori S, Gneri C, Massetani R, Murri L, Fagioli I, Salzarulo P (1998) Slow wave sleep (SWS) distribution across night sleep episode in the elderly. Aging (Milano) 10, 445-448.
17. Fukuda N, Honma H, Kohsaka M, Kobayashi R, Sakakibara S, Kohsaka S, Koyama T (1999) Gender difference of slow wave sleep in middle aged and elderly subjects. Psychiatry Clin Neurosci 53, 151-153.
18. Dorffner G, Vitr M, Anderer P (2015) The effects of aging on sleep architecture in healthy subjects. Adv Exp Med Biol 821, 93-100.
19. Petit D, Gagnon JF, Fantini ML, Ferini-Strambi L, Montplaisir J (2004) Sleep and quantitative EEG in neurodegenerative disorders. J Psychosom Res 56, 487-496.
20. Raggi A, Ferri R (2010) Sleep disorders in neurodegenerative diseases. Eur J Neurol 17, 1326-1328.
21. Bombois S, Derampure P, Pasquier F, Monaca C (2010) Sleep disorders in aging and dementia. J Nutr Health Aging 14, 212-217.
22. Bonanni E, Di Coscio E, Maestri M, Carnicelli L, Tsekou H, Economou NT, Paparrigopoulos T, Bonakis A, Papageor-giou SG, Vassilopoulos D, Soldatos CR, Murri L, Ktonas PY (2012) Differences in EEG delta frequency characteristics and patterns in slow-wave sleep between dementia patients and controls: a pilot study. J Clin Neurophysiol 29, 50-54.
23. Hita-Yanez E, Atienza M, Gil-Neciga E, Cantero JL (2012) Disturbed sleep patterns in elders with mild cognitive impairment: the role of memory decline and ApoE e4 genotype. Curr Alzheimer Res 9, 290-297.
24. Hita-Yanez E, Atienza M, Cantero JL (2013) Polysomno-graphic and subjective sleep markers of mild cognitive impairment. Sleep 36, 1327-1334.
25. Dauvilliers Y (2007) Insomnia in patients with neurodegenerative conditions. Sleep Med 8(Suppl 4), S27-S34.
26. Guarnieri B, Adorni F, Musicco M, Appollonio I, Bonanni E, Caffarra P, Caltagirone C, Cerroni G, Concari L, Cosentino FI, Ferrara S, Fermi S, Ferri R, Gelosa G, Lombardi G, Mazzei D, Mearelli S, Morrone E, Murri L, Nobili FM, Passero S, Perri R, Rocchi R, Sucapane P, Tognoni G, Zabberoni S, Sorbi S (2012) Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients. Dement Geriatr Cogn Disord 33, 50-58.
27. Cervenka S, Palhagen SE, Comley RA, Panagiotidis G, Cselenyi Z, Matthews JC, Lai RY, Halldin C, Farde L (2006) Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain 129(Pt 8), 2017-2028.
28. Ondo WG (2005) Restless legs syndrome. Curr Neurol Neurosci Rep 5, 266-274.
29. Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J (2005) CSF iron, ferritin, and transferrin levels in restless legs syndrome. J Sleep Res 14, 43-47.
30. Connor JR, Ponnuru P, Wang XS, Patton SM, Allen RP, Earley CJ (2011) Profile of altered brain iron acquisition in restless legs syndrome. Brain 134(Pt 4), 959-968.
31. Ohayon MM, O'Hara R, Vitiello MV (2012) Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev 16, 283-295.
32. Talarico G, Canevelli M, Tosto G, Vanacore N, Letteri F, Prastaro M, Troili F, Gasparini M, Lenzi GL, Bruno G (2013) Restless legs syndrome in a group of patients with Alzheimer's disease. Am J Alzheimers Dis Other Demen 28, 165-170.
33. Rose KM, Beck C, Tsai PF, Liem PH, Davila DG, Kleban M, Gooneratne NS, Kalra G, Richards KC (2011) Sleep disturbances and nocturnal agitation behaviors in older adults with dementia. Sleep 34, 779-786.
34. Bliwise DL, Trotti LM, Yesavage JA, Rye DB (2012) Periodic leg movements in sleep in elderly patients with Parkinsonism and Alzheimer's disease. Eur J Neurol 19, 918-923.
35. Gehrman PR, Martin JL, Shochat T, Nolan S, Corey-Bloom J, Ancoli-Israel S (2003) Sleep-disordered breathing and agitation in institutionalized adults with Alzheimer disease. Am J Geriatr Psychiatry 11, 426-433.
36. Yaffe K, Laffan AM, Harrison SL, Redline S, Spira AP, Ensrud KE, Ancoli-Israel S, Stone KL (2011) Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA 306, 613-619.
37. Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, Fujiki N, Nishino S, Holtzman DM (2009) Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 326, 1005-1007.
38. Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, O'Donnell J, Christensen DJ, Nicholson C, Iliff JJ, Takano T, Deane R, Nedergaard M (2013) Sleep drives metabolite clearance from the adult brain. Science 342, 373-377.
39. Djonlagic I, Guo M, Matteis P, Carusona A, Stickgold R, Malhotra A (2014) Untreated sleep-disordered breathing: links to aging-related decline in sleep-dependent memory consolidation. PLoS One 9, 85918.
40. Buratti L, Viticchi G, Falsetti L, Cagnetti C, Luzzi S, Bartolini M, Provinciali L, Silvestrini M (2014) Vascular impairment in Alzheimer's disease: the role of obstructive sleep apnea. J Alzheimers Dis 38, 445-453.
41. O'Hara R, Schröder CM, Kraemer HC, Kryla N, Cao C, Miller E, Schatzberg AF, Yesavage JA, Murphy GM Jr. (2005) Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers. Neurology 65, 642-644.
42. Spira AP, Blackwell T, Stone KL, Redline S, Cauley JA, Ancoli-Israel S, Yaffe K (2008) Sleep-disordered breathing and cognition in older women. J Am Geriatr Soc 56, 45-50.
43. Kadotani H, Kadotani T, Young T, Peppard PE, Finn L, Colrain IM, Murphy GM Jr, Mignot E (2001) Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. JAMA 285, 2888-2900.
44. Gottlieb DJ, DeStefano AL, Foley DJ, Mignot E, Redline S, Givelber RJ, Young T (2004) APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study. Neurology 63, 664-668.
45. Saarelainen S, Lehtimäki T, Kallonen E, Laasonen K, Poussa T, Nieminen MM (1998) No relation between apolipopro-tein E alleles and obstructive sleep apnea. Clin Genet 53, 147-148.
46. Foley DJ, Masaki K, White L, Redline S (2001) Relationship between apolipoprotein E epsilon4 and sleep-disordered breathing at different ages. JAMA 286, 1447-1448.
47. Moe KE, Vitiello MV, Larsen LH, Prinz PN (1995) Symposium: Cognitive processes and sleep disturbances: sleep/wake patterns in Alzheimer's disease: relationships with cognition and function. J Sleep Res 4, 15-20.
48. Wu YH, Feenstra MG, Zhou JN, Liu RY, Toranõ JS, Van Kan HJ, Fischer DF, Ravid R, Swaab DF (2003) Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. J Clin Endocrinol Metab 88, 5898-5906.
49. Ferrari E, Arcaini A, Gornati R, Pelanconi L, Cravello L, Fioravanti M, Solerte SB, Magri F (2000) Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia. Exp Gerontol 35, 1239-1250.
50. Ohashi Y, Okamoto N, Uchida K, Iyo M, Mori N, Morita Y (1999) Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer's type. Biol Psychiatry 45, 1646-1652.
51. Zhou JN, Liu RY, Kamphorst W, Hofman MA, Swaab DF (2003) Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J Pineal Res 35, 125-130.
52. Matsubara E, Bryant-Thomas T, Pacheco Quinto J, Henry TL, Poeggeler B, Herbert D, Cruz-Sanchez F, Chyan YJ, Smith MA, Perry G, Shoji M, Abe K, Leone A, Grundke-Ikbal I, Wilson GL, Ghiso J, Williams C, Refolo LM, Pappolla MA, Chain DG, Neria E (2003) Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. J Neurochem 85, 1101-1108.
53. Naismith SL, Hickie IB, Terpening Z, Rajaratnam SM, Hodges JR, Bolitho S, Rogers NL, Lewis SJ (2014) Circadian misalignment and sleep disruption in mild cognitive impairment. J Alzheimers Dis 38, 857-866.
54. Khachiyants N, Trinkle D, Son SJ, Kim KY (2011) Sundown syndrome in persons with dementia: an update. Psychiatry Investig 8, 275-287.
55. Martin J, Marler M, Shochat T, Ancoli-Israel S (2000) Circadian rhythms of agitation in institutionalized patients with Alzheimer's disease. Chronobiol Int 17, 405-418.
56. Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J (2009) Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 72, 1296-1300.
57. Schenck CH, Mahowald MW, Anderson ML, Silber MH, Boeve BF, Parisi JE (1997) Lewy body variant of Alzheimer's disease (AD) identified by postmortem ubiquitin staining in a previously reported case of AD associated with REM sleep behavior disorder. Biol Psychiatry 42, 527-528.
58. Park M, Shah RC, Fogg LF, Wyatt JK (2011) Daytime sleepiness in mild Alzheimer's disease with and without parkinsonian features. Sleep Med 12, 397-402.
59. Roh JH, Huang Y, Bero AW, Kasten T, Stewart FR, Bateman RJ, Holtzman DM (2012) Disruption of the sleep-wake cycle and diurnal fluctuation of fj-amyloid in mice with Alzheimer's disease pathology. Sci Transl Med 4, 150ra122.
60. Di Meco A, Joshi YB, Pratico D (2014) Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles. Neurobiol Aging 35, 1813-1820.
61. Ooms S, Overeem S, Besse K, Rikkert MO, Verbeek M, Claassen JA (2014) Effect of 1 night of total sleep deprivation on cerebrospinal fluid fj-amyloid 42 in healthy middle-aged men: a randomized clinical trial. JAMA Neurol 71, 971-977.
62. Spira AP, Gamaldo AA, An Y, Wu MN, Simonsick EM, Bil-gel M, Zhou Y, Wong DF, Ferrucci L, Resnick SM (2013) Self-reported sleep and fj-amyloid deposition in community-dwelling older adults. JAMA Neurol 70, 1537-1543.
63. Fronczek R, van Geest S, Frolich M, Overeem S, Roelandse FW, Lammers GJ, Swaab DF (2012) Hypocretin (orexin) loss in Alzheimer's disease. Neurobiol Aging 33, 1642-1650.
64. Liguori C, Romigi A, Nuccetelli M, Zannino S, Sancesario G, Martorana A, Albanese M, Mercuri NB, Izzi F, Bernardini S, Nitti A, Sancesario GM, Sica F, Marciani MG, Placidi F (2014) Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease. JAMA Neurol 71, 1498-1505.
65. Dauvilliers YA, Lehmann S, Jaussent I, Gabelle A (2014) Hypocretin and brain fj-amyloid peptide interactions in cognitive disorders and narcolepsy. Front Aging Neurosci 6, 119.
66. Slats D, Claassen JA, Lammers GJ, Melis RJ, Verbeek MM, Overeem S (2012) Association between hypocretin-1 and amyloid-(342 cerebrospinal fluid levels in Alzheimer's disease and healthy controls. Curr Alzheimer Res 9, 1119-1125.
67. Wennstrom M, Londos E, Minthon L, Nielsen HM (2012) Altered CSF orexin and a-synuclein levels in dementia patients. J Alzheimers Dis 29, 125-132.
68. Deuschle M, Schilling C, Leweke FM, Enning F, Pollmacher T, Esselmann H, Wiltfang J, Frolich L, Heuser I (2014) Hypocretin in cerebrospinal fluid is positively correlated with tttau and pTau. Neurosci Lett 561, 41-45.
69. Schmidt FM, Kratzsch J, Gertz HJ, Tittmann M, Jahn I, Pietsch UC, Kaisers UX, Thiery J, Hegerl U, Schonknecht P (2013) Cerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer's disease. PLoS One 8, e63136.
70. Liu RY, Zhou JN, van Heerikhuize J, Hofman MA, Swaab DF (1999) Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. J Clin Endocrinol Metab 84, 323-327.
71. Nikodemova M, Finn L, Mignot E, Salzieder N, Pep-pard PE (2013) Association of sleep disordered breathing and cognitive deficit in APOE e4 carriers. Sleep 36, 873-880.
72. Lim AS, Yu L, Kowgier M, Schneider JA, Buchman AS, Bennett DA (2013) Modification of the relationship of the apolipoprotein E e4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol 70, 1544-1551.
73. Craig D, Hart DC, Passmore AP (2006) Genetically increased risk of sleep disruption in Alzheimer's disease. Sleep 29, 1003-1007.
74. Yesavage JA, Noda A, Hernandez B, Friedman L, Cheng JJ, Tinklenberg JR, Hallmayer J, O'hara R, David R, Robert P, Landsverk E, Zeitzer JM, Alzheimer's Disease Neuroimag-ing, Initiative (2011) Circadian clock gene polymorphisms and sleep-wake disturbance in Alzheimer disease. Am J Geri-atr Psychiatry 19, 635-643.
75. Chen HF, Huang CQ, You C, Wang ZR, Si-qing H (2013) Polymorphism of CLOCK gene rs 4580704C > G is associated with susceptibility of Alzheimer's disease in a Chinese population. Arch Med Res 44, 203-207.
76. Yang YK, Peng XD, Li YH, Wang ZR, Chang-quan H, Hui W, Liu QX (2013) The polymorphism of CLOCK gene 3111T/C C>T is associated with susceptibility of Alzheimer disease in Chinese population. J Investig Med 61, 1084-1087.
77. Chen Q, Huang CQ, Hu XY, Li SB, Zhang XM (2013) Functional CLOCK gene rs1554483G/C polymorphism is associated with susceptibility to Alzheimer's disease in the Chinese population. J Int Med Res 41, 340-346.
78. Crespo AC, Silva B, Marques L, Marcelino E, Maruta C, Costa S, Timoteo A, Vilares A, Couto FS, Faustino P, Cor-reia AP, Verdelho A, Porto G, Guerreiro M, Herrero A, Costa C, de Mendonca A, Costa L, Martins M (2014) Genetic and biochemical markers in patients with Alzheimer's disease support a concerted systemic iron homeostasis dysregulation. Neurobiol Aging 35, 777-785.
79. Solomon A, Dobranici L, Kareholt I, Tudose C, Lazarescu M (2011) Comorbidity and the rate of cognitive decline in patients with Alzheimer dementia. Int J Geriatr Psychiatry 26, 1244-1251.
80. Valeriani L (2011) Managementofdemented patientsinemer-gency department. Int J Alzheimers Dis 2011, 840312.
81. Martin JL, Ancoli-Israel S (2008) Sleep disturbances in long-term care. Clin Geriatr Med 24, 39-50.
82. Deschenes CL, McCurry SM (2009) Current treatments for sleep disturbances in individuals with dementia. Curr Psychiatry Rep 11, 20-26.